Organon (OGN) and Lilly (LLY) Expand Migraine Commercialization Agreement to 11 Additional Markets
Go back to Organon (OGN) and Lilly (LLY) Expand Migraine Commercialization Agreement to 11 Additional Markets| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1159.15 +6.22 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1152.93 | 52 Week High | $88.16 | |||
| Open | $1144.50 | 52 Week Low | $67.88 | |||
| Day High | $1168.44 | P/E | 268.32 | |||
| Day Low | $1134.41 | EPS | $4.32 | |||
| Volume | 775,962 | |||||
| (NYSE: OGN) | Delayed: 13.75 +0.07 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.68 | 52 Week High | $8.00 | |||
| Open | $13.70 | 52 Week Low | $8.00 | |||
| Day High | $13.75 | P/E | N/A | |||
| Day Low | $13.69 | EPS | $0.00 | |||
| Volume | 693,598 | |||||

